News
Biogen said that new data examining of its already approved spinal muscular atrophy treatment Spinraza (nusinersen) indicates ...
Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 ...
Source Reference: Finkel RS, et al "Risdiplam for prenatal therapy of spinal muscular atrophy" N Engl J Med 2025; DOI: 10.1056/NEJMc2300802.
Maximum mouth opening, which is lower in children with spinal muscular atrophy compared to healthy kids, can be accurately measured during the first 2 years of life. Here’s why that matters.
Spinal muscular atrophy is a debilitating genetic condition that’s usually fatal by a few years of age. But an intriguing case study might demonstrate a simple new treatment, with a child ...
Living with spinal muscular atrophy. DIMITAR DILKOFF/AFP via Getty Images. By Jason Mast. March 19, 2025. General Assignment Reporter Jason Mast [email protected] ...
Spinal muscular atrophy (SMA) is a rare genetic disorder that causes muscle weakness and disability, typically in young children. Learn about symptoms, diagnosis, treatment options, and support.
Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation. Accessibility links. Skip to main content; ...
4d
Investor's Business Daily on MSNCan Biogen Outdo Its Own Spinal Muscular Atrophy Drug?BiogenBIIB said Wednesday its experimental treatment helped children with a devastating muscle-wasting disease even after they received an approved gene therapy from NovartisNVS.The company already ...
Biohaven's spinal muscular atrophy drug fails to meet study goal. By Mariam E Sunny. November 25, 2024 7:06 PM UTC Updated November 25, 2024 Companies; Biohaven Ltd. Follow. Biogen ...
Spinal bulbar muscular atrophy (SBMA) is a progressive genetic neuromuscular condition that affects motor neurons. Over time, it may cause symptoms such as difficulty speaking, swallowing, or walking.
Electrical stimulation of the spinal cord strengthened the muscles of three people with spinal muscular atrophy, a rare motor neuron disease. An experimental treatment that stimulates the spinal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results